Sun Pharma makes waves with jumbo $3.2bn block
Daiichi Sankyo Company has exited from India’s Sun Pharmaceutical Industries in a jumbo Rp200bn ($3.2bn) block trade, pricing one of the largest ever ECM deals in the country. An extensive wall-crossing process over the weekend helped pave the way for the transaction’s execution, which saw a roaring finish despite turbulent market conditions.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts